Diligence memo · auto-generated · as of July 2, 2026
Apton Biosystems, Inc.
Apton Biosystems, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Apton Biosystems, Inc. operates in Other Technology, based in Pleasanton.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Apton Biosystems, Inc. has raised $35M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $25M on 2021-04-14.
Most recent recorded round closed around 2021-04-14.
Valuation (modeled)modeled
Provath models Apton Biosystems, Inc. at approximately $569M (range $60M–$1.9B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.13× the median modeled value of Series B Other Technology companies in 2019–2021 (415 peers) — value vs value, same stage and era. Within the normal band (113% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 24 months.
Last raise 5.2 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 24.6× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 90% of Other Technology peers (21302 compared).
Modeled value ranks above 93% of those peers.
Closest niche peers: Visual Lease, LLC, Decisions, LLC, Suvoda LLC, SmartRecruiters, Inc., Litify Inc..
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.